Analytica Bio Energy Corp Stock Earnings Per Share
Analytica Bio Energy Corp fundamentals help investors to digest information that contributes to Analytica Bio's financial success or failures. It also enables traders to predict the movement of Analytica Stock. The fundamental analysis module provides a way to measure Analytica Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Analytica Bio stock.
Analytica |
Analytica Bio Energy Corp Company Earnings Per Share Analysis
Analytica Bio's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Analytica Bio Earnings Per Share | 0.02 X |
Most of Analytica Bio's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Analytica Bio Energy Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Analytica Bio Energy Corp has an Earnings Per Share of 0.023 times. This is much higher than that of the sector and significantly higher than that of the Earnings Per Share industry. The earnings per share for all United States stocks is notably lower than that of the firm.
Analytica Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Analytica Bio's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Analytica Bio could also be used in its relative valuation, which is a method of valuing Analytica Bio by comparing valuation metrics of similar companies.Analytica Bio is currently under evaluation in earnings per share category among its peers.
Analytica Fundamentals
| Return On Equity | -16.3 | |||
| Return On Asset | -195.14 | |||
| Profit Margin | 311.56 % | |||
| Operating Margin | (49.59) % | |||
| Current Valuation | 536.46 K | |||
| Shares Outstanding | 29.18 M | |||
| Price To Earning | 0.35 X | |||
| Price To Sales | 1.15 X | |||
| Revenue | 202.5 K | |||
| Gross Profit | 62.91 K | |||
| EBITDA | (95.25 K) | |||
| Net Income | 630.92 K | |||
| Cash And Equivalents | 13.74 K | |||
| Total Debt | 316.75 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 0.31 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | 138.73 K | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 3.32 | |||
| Market Capitalization | 233.44 K | |||
| Total Asset | 400 K | |||
| Retained Earnings | (4.68 M) | |||
| Working Capital | (556 K) | |||
| Current Asset | 249 K | |||
| Current Liabilities | 805 K | |||
| Z Score | -16.6 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Analytica Stock
If you are still planning to invest in Analytica Bio Energy check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Analytica Bio's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |